Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription


1 AJR Am J Roentgenol
1 Am J Surg
1 Ann Oncol
1 Ann Surg Oncol
7 Anticancer Res
3 BMC Cancer
4 Breast Cancer Res
3 Breast Cancer Res Treat
1 Cancer
1 Cancer Epidemiol Biomarkers Prev
3 Clin Breast Cancer
1 Curr Treat Options Oncol
3 Eur J Surg Oncol
1 Eur Radiol
1 Histopathology
3 Int J Cancer
1 J Clin Invest
1 J Clin Oncol
2 J Natl Cancer Inst
1 J Pathol
1 Lancet Oncol
1 Nat Rev Cancer
4 Oncogene
2 PLoS One
2 Radiology
1 Radiother Oncol

    AJR Am J Roentgenol

  1. SCHEEL JR, Kim E, Partridge SC, Lehman CD, et al
    MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
    AJR Am J Roentgenol. 2018 Apr 30:1-10. doi: 10.2214/AJR.17.18323.
    >> Share

    Am J Surg

  2. PARK VY, Kim EK, Moon HJ, Yoon JH, et al
    Value of ultrasound-guided fine needle aspiration in diagnosing axillary lymph node recurrence after breast cancer surgery.
    Am J Surg. 2018 Apr 21. pii: S0002-9610(17)31185.
    >> Share

    Ann Oncol

  3. HORTOBAGYI GN, Stemmer SM, Burris HA, Yap YS, et al
    Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
    Ann Oncol. 2018 Apr 27. pii: 4989216. doi: 10.1093.
    >> Share

    Ann Surg Oncol

  4. ELDER K, Nickson C, Pattanasri M, Cooke S, et al
    Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program.
    Ann Surg Oncol. 2018 May 1. pii: 10.1245/s10434-018-6469.
    >> Share

    Anticancer Res

  5. TUNGSUKRUTHAI S, Petpiroon N, Chanvorachote P
    Molecular Mechanisms of Breast Cancer Metastasis and Potential Anti-metastatic Compounds.
    Anticancer Res. 2018;38:2607-2618.
    >> Share

  6. REINHARDT A, Liu H, Ma Y, Zhou Y, et al
    Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
    Anticancer Res. 2018;38:2669-2682.
    >> Share

  7. MINAFRA L, Bravata V, Cammarata FP, Russo G, et al
    Radiation Gene-expression Signatures in Primary Breast Cancer Cells.
    Anticancer Res. 2018;38:2707-2715.
    >> Share

  8. KORONOWICZ AA, Drozdowska M, Banks P, Piasna-Slupecka E, et al
    Fatty Acids of CLA-enriched Egg Yolks Can Induce Mitochondrial Pathway of Apoptosis in MCF-7 Breast Cancer Cells.
    Anticancer Res. 2018;38:2861-2870.
    >> Share

  9. GOTO W, Kashiwagi S, Asano Y, Takada K, et al
    Eribulin Promotes Antitumor Immune Responses in Patients with Locally Advanced or Metastatic Breast Cancer.
    Anticancer Res. 2018;38:2929-2938.
    >> Share

  10. LUMACHI F, Basso SMM, Camozzi V, Spaziante R, et al
    Bone Mineral Density as a Potential Predictive Factor for Luminal-type Breast Cancer in Postmenopausal Women.
    Anticancer Res. 2018;38:3049-3054.
    >> Share

  11. CHANG J, Charalel R, Noda C, Ramaswamy R, et al
    Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Versus Radioembolization.
    Anticancer Res. 2018;38:3063-3068.
    >> Share

    BMC Cancer

  12. LI W, Xu L, Che X, Li H, et al
    C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells.
    BMC Cancer. 2018;18:507.
    >> Share

  13. DI GIROLAMO C, Walters S, Benitez Majano S, Rachet B, et al
    Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013.
    BMC Cancer. 2018;18:492.
    >> Share

  14. FERNANDO A, Jayarajah U, Prabashani S, Fernando EA, et al
    Incidence trends and patterns of breast cancer in Sri Lanka: an analysis of the national cancer database.
    BMC Cancer. 2018;18:482.
    >> Share

    Breast Cancer Res

  15. KISH JK, Ward MA, Garofalo D, Ahmed HV, et al
    Real-world evidence analysis of palbociclib prescribing patterns for patients with advanced/metastatic breast cancer treated in community oncology practice in the USA one year post approval.
    Breast Cancer Res. 2018;20:37.
    >> Share

  16. WANDERS JOP, van Gils CH, Karssemeijer N, Holland K, et al
    The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Breast Cancer Res. 2018;20:36.
    >> Share

  17. CHEN BT, Sethi SK, Jin T, Patel SK, et al
    Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
    Breast Cancer Res. 2018;20:38.
    >> Share

  18. PADUA MB, Bhat-Nakshatri P, Anjanappa M, Prasad MS, et al
    Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
    Breast Cancer Res. 2018;20:35.
    >> Share

    Breast Cancer Res Treat

  19. KIM S, Ko Y, Lee HJ, Lim JE, et al
    Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies.
    Breast Cancer Res Treat. 2018 Apr 30. pii: 10.1007/s10549-018-4782.
    >> Share

  20. ERIN N, Ogan N, Yerlikaya A
    Correction to: Secretomes reveal several novel proteins as well as TGF-beta1 as the top upstream regulator of metastatic process in breast cancer.
    Breast Cancer Res Treat. 2018 May 2. pii: 10.1007/s10549-018-4781.
    >> Share

  21. KOMMALAPATI A, Tella SH, Goyal G, Ganti AK, et al
    A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
    Breast Cancer Res Treat. 2018 May 2. pii: 10.1007/s10549-018-4802.
    >> Share


  22. VALACHIS A, Mamounas EP, Mittendorf EA, Hayashi N, et al
    Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.
    Cancer. 2018 May 3. doi: 10.1002/cncr.31518.
    >> Share

    Cancer Epidemiol Biomarkers Prev

  23. FARVID MS, Eliassen AH, Cho E, Chen WY, et al
    Dairy Consumption in Adolescence and Early Adulthood and Risk of Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2018;27:575-584.
    >> Share

    Clin Breast Cancer

  24. NG T, Phey XY, Yeo HL, Shwe M, et al
    Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Clin Breast Cancer. 2018 Apr 6. pii: S1526-8209(17)30767.
    >> Share

  25. UM E, Kang JW, Lee S, Kim HJ, et al
    Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30614.
    >> Share

  26. CORTES J, Perez-Garcia J, Whiting S, Wan Y, et al
    Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis.
    Clin Breast Cancer. 2018 Mar 30. pii: S1526-8209(17)30778.
    >> Share

    Curr Treat Options Oncol

  27. VAN HELLEMOND IEG, Geurts SME, Tjan-Heijnen VCG
    Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer.
    Curr Treat Options Oncol. 2018;19:26.
    >> Share

    Eur J Surg Oncol

  28. LIM GH, Upadhyaya VS, Acosta HA, Lim JMA, et al
    Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
    Eur J Surg Oncol. 2018 Apr 12. pii: S0748-7983(18)31008.
    >> Share

  29. CSERNI G, Charafe-Jauffret E, van Diest PJ
    Inflammatory breast cancer: The pathologists' perspective.
    Eur J Surg Oncol. 2018 Apr 18. pii: S0748-7983(18)30998.
    >> Share

  30. WICKBERG A, Liljegren G, Killander F, Lindman H, et al
    Omitting radiotherapy in women >/= 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Eur J Surg Oncol. 2018 Apr 13. pii: S0748-7983(18)31007.
    >> Share

    Eur Radiol

  31. KIM JY, Kim JJ, Kim S, Choo KS, et al
    Diffusion tensor magnetic resonance imaging of breast cancer: associations between diffusion metrics and histological prognostic factors.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5429.
    >> Share


  32. JOSEPH C, Papadaki A, Althobiti M, Alsaleem M, et al
    Breast cancer intra-tumour heterogeneity: Current status and clinical implications.
    Histopathology. 2018 May 2. doi: 10.1111/his.13642.
    >> Share

    Int J Cancer

  33. LI J, Wang W, Xia P, Wan L, et al
    Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in breast cancer patients.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31573.
    >> Share

  34. CAIRAT M, Fournier A, Murphy N, Biessy C, et al
    Nonsteroidal anti-inflammatory drug use and breast cancer risk in a European prospective cohort study.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31570.
    >> Share

  35. BAGLIA ML, Cook LS, Tang MT, Wiggins C, et al
    Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer.
    Int J Cancer. 2018 Apr 30. doi: 10.1002/ijc.31575.
    >> Share

    J Clin Invest

  36. YU J, Qin B, Moyer AM, Nowsheen S, et al
    DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.
    J Clin Invest. 2018 Apr 30. pii: 97924. doi: 10.1172/JCI97924.
    >> Share

    J Clin Oncol

  37. LAMBERTINI M, Moore HCF, Leonard RCF, Loibl S, et al
    Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
    J Clin Oncol. 2018 May 2:JCO2018780858. doi: 10.1200/JCO.2018.78.0858.
    >> Share

    J Natl Cancer Inst

  38. JAYASEKERA J, Li Y, Schechter CB, Jagsi R, et al
    Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.
    J Natl Cancer Inst. 2018 Apr 28. pii: 4990602. doi: 10.1093.
    >> Share

  39. DESMEDT C, Demicheli R, Fornili M, Bachir I, et al
    Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index.
    J Natl Cancer Inst. 2018 Apr 30. pii: 4975381. doi: 10.1093.
    >> Share

    J Pathol

  40. BARTELS S, van Luttikhuizen JL, Christgen M, Magel L, et al
    CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
    J Pathol. 2018 Apr 30. doi: 10.1002/path.5091.
    >> Share


  41. KEATING NL, Pace LE
    Breast Cancer Screening in 2018: Time for Shared Decision Making.
    JAMA. 2018;319:1814-1815.
    >> Share

    Lancet Oncol

  42. PERNAS S, Martin M, Kaufman PA, Gil-Martin M, et al
    Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
    Lancet Oncol. 2018 Apr 26. pii: S1470-2045(18)30147.
    >> Share

    Nat Rev Cancer

  43. LIM B, Woodward WA, Wang X, Reuben JM, et al
    Inflammatory breast cancer biology: the tumour microenvironment is key.
    Nat Rev Cancer. 2018 Apr 27. pii: 10.1038/s41568-018-0010.
    >> Share


  44. CHEN A, Sceneay J, Godde N, Kinwel T, et al
    Intermittent hypoxia induces a metastatic phenotype in breast cancer.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0259.
    >> Share

  45. PAVAN S, Meyer-Schaller N, Diepenbruck M, Kalathur RKR, et al
    A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0270.
    >> Share

  46. CHANG JW, Kuo WH, Lin CM, Chen WL, et al
    Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0253.
    >> Share

  47. AHIRWAR DK, Nasser MW, Ouseph MM, Elbaz M, et al
    Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0263.
    >> Share

    PLoS One

  48. FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
    Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    PLoS One. 2018;13:e0196892.
    >> Share

  49. VERONESE P, Hachul DT, Scanavacca MI, Hajjar LA, et al
    Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer.
    PLoS One. 2018;13:e0196763.
    >> Share


  50. GILLIES RJ, Balagurunathan Y
    Perfusion MR Imaging of Breast Cancer: Insights Using "Habitat Imaging".
    Radiology. 2018 Apr 27:180271. doi: 10.1148/radiol.2018180271.
    >> Share

  51. WU J, Cao G, Sun X, Lee J, et al
    Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Radiology. 2018 Apr 27:172462. doi: 10.1148/radiol.2018172462.
    >> Share

    Radiother Oncol

  52. GERNAAT SAM, van Velzen SGM, Koh V, Emaus MJ, et al
    Automatic quantification of calcifications in the coronary arteries and thoracic aorta on radiotherapy planning CT scans of Western and Asian breast cancer patients.
    Radiother Oncol. 2018 Apr 24. pii: S0167-8140(18)30199.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016